Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
131I-MIBG Therapy for MIBG Avid Tumors
NCT02378428Phase 2Active, not recruiting
- Sponsor
- Nationwide Children's Hospital
- Start
- Mar 2014
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Iobenguane I-131 in neuroblastoma, pheochromocytoma, Paraganglioma (PGL), sponsored by Nationwide Children's Hospital. Started Mar 2014; status: active, not recruiting.
02
Drugs
Iobenguane I-131
03
Conditions
neuroblastomapheochromocytomaParaganglioma (PGL)
Beyond the preview
Go deeper on NCT02378428.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02378428.